Abstract
Introduction

Survivin (encoded by BIRC5) is the smallest member of the family of inhibitor of apoptosis proteins (IAPs). It consists of 142 amino acids comprising a 16.5-kD protein and may present in the form of different splice variants. Transcription of survivin is controlled by direct binding of oncogenic transcription factor STAT3, TCF-4 and tumour suppressor p53 to the promoter of BIRC5 gene
. At the post-transcriptional level, survivin is stabilized by binding to molecular chaperones, including AIP and HSP90 [3] [4] [5] . Binding to chaperones facilitates translocation of survivin into mitochondria, where it accomplishes its cytoprotective effects through regulation of hepatitis B X-interacting protein, Smac/Diablo and X-linked IAP system of molecules [1, 6, 7] . [8, 9] . [3] . Furthermore, levels of survivin in cancer cells correlates to poor prognosis and resistance to chemotherapeutic treatment [10, 11] . Fukuda and Pelus reviewed recent studies on a role for survivin in regulating function in normal cells under renewal and proliferation [12] . [13] . [14] . Survivin expression in endothelial cells is recognized as an important mechanism of vascular remodelling. Indeed, disruption of survivin abrogates regeneration of endothelial cells and angiogenesis in response to vascular endothelial growth factor, basic fibroblast growth factor and angiogenic cytokines angiopoietin 1 and angiotensin II [15, 16] . In rheumatoid arthritis (RA), the hypertrophic synovial tissue forms pannus, which mimics the proliferative and invasive features of neoplasia invading and destroying periarticular cartilage and bone [17] . Deregulation of apoptosis machinery and p53-dependent cell damage control has been outlined among the major events responsible for synovial transformation [18] [19] [20] . We [23, 27] . Furthermore, it has been shown that tumour dormancy is induced by down-regulation of uPAR in cancer cells involving integrin and MAPK signalling [28] . Activation of plasminogen in the inflamed RA joints is regulated by interleukin-1 [29, 30] , potentially through its interaction with Toll/IL-1 receptor system of intracellular signalling. Rheumatoid synovial fibroblasts exhibit considerably increased uPA activity over the proliferating lining areas [31, 32] . Moreover, expression of uPA inside the joints has been shown to be both essential and sufficient for the development of arthritis [32] [33] [34] . [21] . (Fig. 1A and B) . The levels of uPA and survivin strongly correlated to each other (r ϭ 0.46, P ϭ 0.0015). Immunological evaluation of human synovia visualized the presence of survivin in the intimal lining layer (Fig. 1C) , whereas uPA expression was observed both in the lining layer and in leucocytes infiltrating synovia (Fig. 1D) . (Fig. 2) . Leucocytes from synovial fluid and peripheral blood produced no detectable levels of uPA, whereas flow cytometry revealed expression of uPAR on human peripheral blood leucocytes. Fig. 2A and B) . Fig. 2E and F (Fig. 3A) . Simultaneously, (Fig. 4B ). (Fig. 6B) . (Fig. 6C) . In addition, inhibition of PI3-kinase did not change IL-8 production in THP-1 cells (Fig. 6D) . [37, 38] . In contrast, disruption of PI3-kinase using a selective PI3-kinase gamma inhibitor ameliorated development of the collagen type II-induced arthritis [39] [40] [41] .
Survivin displays a sharp cell cycle-dependent expression in the G2/M phase. It regulates cell cycle progression and mitosis by acting as a subunit in chromosomal passenger complex
Survivin interacts with a high number of proteins, regulators, transcriptional networks and modifiers, which establishes survivin as a key molecule expanding multiple parallel signalling in cellular homeostasis. Expression of survivin is highly up-regulated in malignancy, being involved in the critical determinants of tumour progression such as cell proliferation, evasion of apoptosis, resistance to growth-inhibitory signals and angiogenesis
Studies on T cell development in mice using conventional knockout models showed that loss of survivin at early stages blocked transition of thymocytes from the double-negative to the doublepositive stage, whereas survivin deletion at late stages decreased
Survivin is an essential mediator of arthritis interacting with urokinase signalling
A requirement of survivin has been recently shown for the OX40-induced proliferation of effector T cells regulating G1-S transition in mature T cells
Determination of cytokine levels
Statistical analysis
Synovial fibroblasts are a source of uPA in synovial fluid
Common intracellular pathways regulate synthesis of uPA and survivin
Primary synovial fibroblasts and MRC-5 cells were cultured in the presence of specific inhibitors targeting tyrosine kinases (genistein), MEK (PD98059), PI3-kinase (LY294002) and NF-B (parthenolide) signalling pathways and their effects on synthesis of survivin, uPA and IL-8 were evaluated. Synthesis of uPA in
Fig. 1 Levels of uPA in blood and synovial fluid in patients with rheumatoid arthritis stratified according to levels of survivin and presence of joint destructions. Levels of uPA and survivin were measured in the paired blood and synovial fluid samples of 132 patients and exhibited significant correlation (r ϭ 0.46, P ϭ 0.0015). (A) The patients having joint destruction (erosive group, n ϭ 70) had significantly higher uPA levels as compared with those without destruction (non-erosive, n ϭ 62). (B) The levels of uPA were significantly higher in blood and synovial fluid of the patients having high survivin levels. (C) Immunohistochemical staining of human synovial tissue for the expression of survivin (reddish-brown staining) in the lining layer of synovial fibroblast-like cells. (D) Expression of uPA (reddish-brown staining) in the lining areas of synovia and in the inflammatory cell infiltrate. (E) Immunohistochemical staining of human synovial tissue using mouse IgG (negative control). Bar size 100 m. Nuclei are counterstained with haematoxylin. primary synovial fibroblasts as well as in MRC-5 cells was dependent on the activity of tyrosine kinases, PI3-kinase and MEK (
In contrast, blocking of NF-B pathway with parthenolide did not significantly change uPA synthesis in synovial fibroblasts. Inhibition of tyrosine kinases, PI3-kinase and MEK significantly decreased intracellular expression of survivin (Fig. 2C and D). In synovial fibroblasts, the expression of survivin exhibited the same overall trend as uPA, with the exception of the introduction of PI3-kinase inhibitor that had no inhibitory effect on survivin in synovial fibroblasts. The expression of survivin was not dependent on the activity of NF-B either in primary synovial fibroblast cultures or in MRC-5 cells. To exclude the non-specific suppressive effect of intracellular inhibitors on viability and function of cell cultures, the levels of IL-8 were measured in the supernatants of the primary synovial fibroblast cultures as well as of MRC-5. The inhibitors of tyrosine kinases, PI3-kinase, NF-B and MEK had no effect on the production of IL-8 in the tested cell cultures (
Fig. 2 Intracellular regulation of uPA and survivin production in primary synovial fibroblasts and MRC-5 fibroblast cell line. Primary synovial flibroblasts were obtained from synovial tissue of RA patients (n ϭ 3). Cells in passage 3-5 were used in the experiments (open bars). MRC-5 was used in passage 15-20 (black-filled bars). Cells (2 ϫ 10 5 /ml) were cultured in the presence of specific inhibitors of tyrosine kinases (ginestein), PI3-kinase (LY294002), MEK 1 (PD98059) and NF-B (parthenolide), all in a final concentration of 50 M. The uPA levels were measured in the supernatants following 48 hrs (A, B). The levels of survivin were measured in cell lysates (C, D). To reassure the viability of cell cultures, supernatants were also evaluated for IL-8 (E, F). Differences in comparison to
Survivin production is essential for the uPAinduced up-regulation of uPAR
Flow cytometric evaluation of THP-1 cells revealed expression of uPAR. uPAR was further up-regulated on the cell surface following uPA stimulation (300 UI/ml) (Fig. 5A). THP-1 cells were transfected with siRNA targeting survivin (50 nM) and non-targeting RNA sequence. Successful inhibition of survivin was proved in the THP-1 lysates (not shown). Flow cytometric evaluation of the transfected cells showed a significant reduction of uPAR expression on the cell surface as a result of survivin targeting transfection (Fig. 5B). © 2009 The Authors Journal compilation © 2009 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 The production of uPA in human fibroblasts is survivin dependent. MRC-5 cells were seeded overnight in antibiotic-free medium in a concentration of 2.5 ϫ 10 5 /ml. Cells were transfected with siRNA targeting survivin gene (50 and 100 nM) and non-targeting RNA (Mock) for 4 hrs. Transfection was stopped by addition of antibiotics. The levels of uPA were measured in the supernatants following 48 and 72 hrs of incubation (A). A significant time-dependent decrease of uPA was observed in the cultures where survivin transcription was down-regulated. Successful transfection with siRNA was proved by a decrease of intracellular survivin levels measured in the lysates of the same cells (B). To evaluate if survivin synthesis was dependent on
The role of PI3-kinase in uPA-induced survivin synthesis
The role of survivin in experimental arthritis
Evaluation of uPA signalling in human leucocytes enlightened a different relationship between uPA and survivin expression in these cells (Fig. 8) [45] . The results of our study in combination with the results of Sekine et al. [45] show that survivin targeting strategies may present a new direction in the treatment of arthritis.
